AllPeptides.eu - Advanced Peptide Research
    Single Peptides
    Bioregulator

    Vilon (20mg)

    Subcutaneous injectionDaily20mg

    Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-06-16

    🇷🇺 МЗ РФ (Вилон®)

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Approved by select regulatory agencies — not FDA/EMA
    Educational information. Not medical advice or a recommendation for use.

    ⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer

    Free Access

    How It Works

    Vilon (KE sequence) epigenetically regulates gene expression in thymocytes, enhancing thymic function, T-cell maturation, and overall immune competence. It is the most studied dipeptide bioregulator.

    Quick Start

    • Typical Dose: 1–2mg subcutaneously
    • Frequency: Daily for 10–20 days
    • Storage: 2–8°C after reconstitution
    Detailed Protocol Data

    Dosing Table — Vilon 20mg

    Educational only
    Vial Size— affects syringe units
    BAC Water2 mL
    Concentration10.00 mg/mL

    Route: Subcutaneous injection | Frequency: Daily

    WeekDoseUnits (per injection)
    1–2
    1mg
    10 Units (0.10 mL)
    3+
    2mg
    20 Units (0.20 mL)

    10–20 day cycle, repeated every 3–6 months. The smallest Khavinson bioregulator peptide (dipeptide).

    Related compounds

    Reconstitution Steps

    1. Clean the stoppers with an alcohol wipe.
    2. Draw up 2mL of bacteriostatic water.
    3. Slowly inject against the wall of the vial.
    4. Gently swirl until fully dissolved.
    5. Store in the refrigerator (2–8°C).

    Protocol Overview

    • Thymus bioregulator — the smallest peptide (KE) in the Khavinson series.
    • Regulates thymic function and T-lymphocyte maturation.
    • Anti-aging action via immune system rejuvenation.

    Dosing Protocol

    • 1–2mg/day for 10–20 days.
    • Repeat every 3–6 months.
    • Combines well with Crystagen (immune) and Epithalon (telomerase).
    • Break between cycles: After the cycle (10–20 days), a 3–6 month break is recommended. Khavinson bioregulator peptides — typically 2–3 cycles/year.

    Washout & Cycle Restart

    When can I restart?

    After the cycle (10–20 days), a 3–6 month break is recommended. Khavinson bioregulator peptides — typically 2–3 cycles/year.

    Minimum wait period: 12 weeks

    Storage Instructions

    • Reconstituted: 2–8°C, use within 21 days.
    • Powder: 2–8°C.

    Important Notes

    • Extremely important after age 40 — the thymus atrophies with age.
    • Contraindicated in autoimmune diseases without medical guidance.
    • Cumulative action.
    Clinical Analysis & Safety

    Potential Benefits & Side Effects

    Potential Benefits:

    • Thymus gland rejuvenation
    • Enhancement of T-cell immunity
    • Anti-aging effects
    • Improved immune response
    • Regulation of inflammation

    Potential Side Effects:

    • Mild injection site irritation
    • Rare: transient fatigue (immune activation)

    ⚠️ Serious Warnings & Long-Term Risks

    The following warnings are based on published literature, FDA labels, and post-marketing surveillance. They do not constitute medical advice. Consult a healthcare professional.

    ⚠️ Other
    🟡 Moderate / Theoretical

    Immunostimulatory di-peptide — risk in autoimmune conditions

    Vilon (Lys-Glu) activates thymic function. Contraindicated in active autoimmune diseases. Limited data outside Russian literature.

    📄 Khavinson VK — Bull Exp Biol Med

    References

    1. Vilon Thymus Bioregulation — Khavinson VK, et al. Effect of Vilon on thymocyte differentiation. Bull Exp Biol Med. 2000;130(11):1033-1035.
      View Source
    2. Khavinson Peptides — Khavinson VK. Peptides and Ageing. Neuroendocrinol Lett. 2002;23 Suppl 3:11-144.
      View Source

    Recommended Supplements

    Research Sources & Verified Data
    …
    Clinical Trials
    …
    PubMed Studies
    Research-only
    FDA Status
    1
    Regulatory Approvals
    Verified across ClinicalTrials.gov, PubMed & FDA

    External Sources & Regulatory Status

    Regulatory Approvals

    🇷🇺
    МЗ РФ
    Approved

    Вилон® · Immune system / Anti-ageing (2007)

    Approved in Russia (Khavinson bioregulator)

    No official regulatory source available yet — research peptide.

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Summary:
    1 Approvals
    0 PubMed
    0 Clinical Studies

    Continue Your Research

    Explore tools and guides related to this protocol.

    Educational contentRegularly reviewed & maintainedEvidence-based review

    Important Disclaimer

    The content of this website is provided exclusively for informational and educational purposes within the context of research literature.

    Read the full Disclaimer →

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu